This opportunity is no longer accepting applications.
grant HT942524DMRDPPTRCTA

DoD Psychedelic Treatment Research Clinical Trial Award

The DMRDP PTRCTA grant supports clinical trials focused on treating PTSD and/or TBI among U.S. Service Members using certain psychedelic substances. Eligible trials should target one or both of these conditions and may use substances like MDMA, psilocybin, ibogaine, 5-MeO-DMT, and plant-based therapies, either alone or with other treatments. The trials can range from small, proof-of-concept st…

The intent of the DMRDP PTRCTA is to support clinical trials with eligible U.S. Service Members to evaluate treatments for post-traumatic stress disorder (PTSD) and/or traumatic brain injury (TBI) involving the use of covered psychedelic substances. Applicants must select at least one of the two…

Funding Source

Agency: Dept. of the Army -- USAMRAA
Program: SBIR

Awards & funding

Total Funding: $9.8M
Total Awards Given 2

Dates

Opportunity Released: July 30, 2024
Open for Submission: July 30, 2024
Submission Deadline: October 4, 2024
Application Window Closes: October 4, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.